Gralow Ingrid
Leiterin der Schmerzambulanz und -Tagesklinik der Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Münster.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2010 Jan;45(1):34-42. doi: 10.1055/s-0029-1243377. Epub 2010 Jan 20.
Cancer-related pain affects approximately about 30 to 80 % of all patients, according to primary and metastatic sides and stage of disease. Cancer pain management depends on the underlying pathophysiological mechanisms. Current pain treatment is still based on the World Health Organisation (WHO-"ladder") - guidelines, opioid therapy beeing the cornerstone. The present overview article focuses on different opioids, as well as on the various adjuvants. Advantages and side effects of the different nonopioids, anticonvulsants, and antidepressants are discussed. The recommendations are limited for the adult outpatient treatment.
根据疾病的原发和转移部位及阶段,癌症相关疼痛影响约30%至80%的所有患者。癌症疼痛管理取决于潜在的病理生理机制。目前的疼痛治疗仍基于世界卫生组织(WHO - “三阶梯”)指南,阿片类药物治疗是基石。本综述文章重点关注不同的阿片类药物以及各种辅助药物。讨论了不同非阿片类药物、抗惊厥药和抗抑郁药的优缺点。这些建议限于成人门诊治疗。